Loading...

ICCC IMMUCELL CORP Management Changes 8-K Filing

MMCL

CCC

IMMUCELL CORP

(ICCC)

2025 8-K

Settlement Agreement

Board Changes Announced

Sales Growth Report

Financial Results Release

Management Changes

Sales Results Update

Strategy Change Announcement

Financial Results Announced

Management Changes

Sales Announcement

CEO Appointment

Credit Extension Agreement

Quarterly Results

Financial Statements

Leadership Changes

Financial Statements

Sales Announcement

Management Change

Financial Results

Insurance Settlement

Sales Announcement

Management Change

Contract Amendment

Sales Announcement

Lease Amendment

Financial Results

Financial Results

Lease Amendment

Annual Meeting of Stockholders

Financial Results Announcement

Agreement for Stock Offering

Financial Results

Agreement Termination

Line of Credit Extension

Earnings Reports

Financial Results

Lease Amendment

Financial Results Announcement

Financial Results

Financial Results Announcement

Debt-Equity Swaps

Regulation FD Disclosure

Financial Results

Financial Results Announcement

Financial Results

External Links:

ImmuCell Corp announced that as of November 1, 2025, Olivier te Boekhorst will become the new President and CEO, replacing Michael F. Brigham, who transitions to a Special Advisor role. The Board also expanded from seven to nine directors, electing both te Boekhorst and CFO Timothy C. Fiori as directors, with Fiori also taking on the roles of Secretary and Treasurer.

AI Assistant

IMMUCELL CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.